BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22155006)

  • 1. Reduced cardiac CapZ protein protects hearts against acute ischemia-reperfusion injury and enhances preconditioning.
    Yang FH; Pyle WG
    J Mol Cell Cardiol; 2012 Mar; 52(3):761-72. PubMed ID: 22155006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying a role of the actin capping protein CapZ in β-adrenergic receptor signalling.
    Gaikis L; Stewart D; Johnson R; Pyle WG
    Acta Physiol (Oxf); 2013 Jan; 207(1):173-82. PubMed ID: 22882973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of cardiac myofilament activation and PKC-betaII signaling through the actin capping protein, CapZ.
    Pyle WG; La Rotta G; de Tombe PP; Sumandea MP; Solaro RJ
    J Mol Cell Cardiol; 2006 Sep; 41(3):537-43. PubMed ID: 16870209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac actin capping protein reduction and protein kinase C inhibition maintain myofilament function during cardioplegic arrest.
    Yang FH; Pyle WG
    Cell Physiol Biochem; 2011; 27(3-4):263-72. PubMed ID: 21471715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac myofilament regulation by protein phosphatase type 1alpha and CapZ.
    Yang F; Aiello DL; Pyle WG
    Biochem Cell Biol; 2008 Feb; 86(1):70-8. PubMed ID: 18364747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ischemia postconditioning on ischemia-reperfusion injury and reperfusion injury salvage kinase signal transduction pathways in isolated mouse hearts].
    Zhang JF; Ma YT; Yang YN; Gao XM; Liu F; Chen BD; Li XM; Xiang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Feb; 36(2):161-6. PubMed ID: 19099957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actin capping protein: an essential element in protein kinase signaling to the myofilaments.
    Pyle WG; Hart MC; Cooper JA; Sumandea MP; de Tombe PP; Solaro RJ
    Circ Res; 2002 Jun; 90(12):1299-306. PubMed ID: 12089068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
    Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
    Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Rohilla A; Singh G; Singh M; Bala kumar P
    Biomed Pharmacother; 2010 Mar; 64(3):195-202. PubMed ID: 19914792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased particulate partitioning of PKC epsilon reverses susceptibility of phospholamban knockout hearts to ischemic injury.
    Gregory KN; Hahn H; Haghighi K; Marreez Y; Odley A; Dorn GW; Kranias EG
    J Mol Cell Cardiol; 2004 Feb; 36(2):313-8. PubMed ID: 14871559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning.
    Heinen NM; Pütz VE; Görgens JI; Huhn R; Grüber Y; Barthuber C; Preckel B; Pannen BH; Bauer I
    Shock; 2011 Jul; 36(1):45-53. PubMed ID: 21478813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute memory phase of sevoflurane preconditioning is associated with sustained translocation of protein kinase C-alpha and epsilon, but not delta, in isolated guinea pig hearts.
    Okusa C; Miyamae M; Sugioka S; Kaneda K; Inamura Y; Onishi A; Domae N; Kotani J; Figueredo VM
    Eur J Anaesthesiol; 2009 Jul; 26(7):582-8. PubMed ID: 19390447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.
    Jin ZQ; Zhang J; Huang Y; Hoover HE; Vessey DA; Karliner JS
    Cardiovasc Res; 2007 Oct; 76(1):41-50. PubMed ID: 17610857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.
    Lange SA; Wolf B; Schober K; Wunderlich C; Marquetant R; Weinbrenner C; Strasser RH
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):46-55. PubMed ID: 17261963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion.
    Kuno A; Critz SD; Cui L; Solodushko V; Yang XM; Krahn T; Albrecht B; Philipp S; Cohen MV; Downey JM
    J Mol Cell Cardiol; 2007 Sep; 43(3):262-71. PubMed ID: 17632123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning.
    Ban K; Cooper AJ; Samuel S; Bhatti A; Patel M; Izumo S; Penninger JM; Backx PH; Oudit GY; Tsushima RG
    Circ Res; 2008 Sep; 103(6):643-53. PubMed ID: 18688045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.